Literature DB >> 2069219

Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports.

J Ingram1, S Weitzman, M L Greenberg, P Parkin, R Filler.   

Abstract

Since 1984, 316 subcutaneous ports (SP) and 339 external venous catheters (EC) [Roko Catheter, The Hospital for Sick Children (HSC)] have been inserted in hematology/oncology patients at HSC. During a 22-month period (July 1987 to April 1989), a committed central line nurse (J.I.) prospectively collected clinical and microbiologic data on 144 consecutive SPs and 130 consecutive ECs. Children with the SP had 0.6 infected lines and 0.7 infectious episodes per 1,000 patient days compared to 2.9 infected lines and 4.3 infectious episodes per 1,000 patient days with the EC (p less than 0.001). This lower infectious complication rate with SP was demonstrated in the entire group of unselected patients and in a cohort of children with acute lymphoblastic leukemia (ALL) receiving intensive chemotherapy, and it was evident in all age groups. In view of the other advantages of SP--normal activity, absence of the need for home maintenance, improved body image, less expense--these data suggest that SPs are the preferred device in pediatric patients and provide effective venous access with acceptable complication rates.

Entities:  

Mesh:

Year:  1991        PMID: 2069219     DOI: 10.1097/00043426-199122000-00003

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  24 in total

1.  Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).

Authors:  T U Anthony; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.

Authors:  Michael L Rinke; David G Bundy; Aaron M Milstone; Kristin Deuber; Allen R Chen; Elizabeth Colantuoni; Marlene R Miller
Journal:  Jt Comm J Qual Patient Saf       Date:  2013-08

3.  Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications.

Authors:  Giovanna Masci; Massimo Magagnoli; Vittorio Pedicini; Dario Poretti; Luca Castagna; Carlo Carnaghi; Emanuela Morenghi; Antonietta Del Vecchio; Rita Finotto; Giorgio Brambilla; Armando Santoro
Journal:  Support Care Cancer       Date:  2006-04-19       Impact factor: 3.603

Review 4.  Pediatric vascular access.

Authors:  James S Donaldson
Journal:  Pediatr Radiol       Date:  2006-03-15

5.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

6.  A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital.

Authors:  M Pinon; S Bezzio; P A Tovo; F Fagioli; L Farinasso; R Calabrese; M Marengo; M Giacchino
Journal:  Eur J Pediatr       Date:  2009-03-17       Impact factor: 3.183

7.  Central venous catheter use in UKCCSG oncology centres. United Kingdom Children's Cancer Study Group and the Paediatric Oncology Nursing Forum.

Authors:  D A Tweddle; K P Windebank; A M Barrett; D C Leese; R Gowing
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

8.  Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.

Authors:  Michael L Rinke; Allen R Chen; David G Bundy; Elizabeth Colantuoni; Lisa Fratino; Kim M Drucis; Stephanie Y Panton; Michelle Kokoszka; Alicia P Budd; Aaron M Milstone; Marlene R Miller
Journal:  Pediatrics       Date:  2012-09-03       Impact factor: 7.124

9.  It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.

Authors:  Nuriye Yildirim Ozdemir; Hüseyin Abali; Berna Oksüzoğlu; Burçin Budakoğlu; Ilkay Akmangit; Nurullah Zengin
Journal:  Support Care Cancer       Date:  2008-09-02       Impact factor: 3.603

10.  Implantable venous port-related infections in cancer patients.

Authors:  Wen-Tsung Huang; Tsai-Yun Chen; Wu-Chou Su; Chia-Jui Yen; Chao-Jung Tsao
Journal:  Support Care Cancer       Date:  2004-01-16       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.